JPY 1830.0
(0.77%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.93 Billion | -279 Million | 5.15 Billion | 7.36 Billion | 6.73 Billion | 4.68 Billion |
Net Income | 4.44 Billion | 5.71 Billion | 6.82 Billion | 5.62 Billion | 5.88 Billion | 6.52 Billion |
Depreciation & Amortization | 2.25 Billion | 1.96 Billion | 2.07 Billion | 2.34 Billion | 2.05 Billion | 2.1 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -2.23 Billion | -7.04 Billion | -1.93 Billion | 736 Million | -757 Million | -1.18 Billion |
Other non-cash items | 470 Million | -912 Million | -1.82 Billion | -1.34 Billion | -442 Million | -2.76 Billion |
Investing Cash Flow | -2.07 Billion | -2.58 Billion | -799 Million | -1.6 Billion | -1.26 Billion | -2.5 Billion |
Investments in PPE | -1.97 Billion | -1.71 Billion | -1.08 Billion | -1.25 Billion | -1.4 Billion | -1.9 Billion |
Acquisitions | -3 Million | - | 270 Million | -169 Million | -236 Million | -319 Million |
Investment purchases | -4.09 Billion | -4.36 Billion | -1 Billion | -668 Million | -479 Million | -998 Million |
Sales/Maturities of investments | 4.19 Billion | 3.5 Billion | 1.28 Billion | 310 Million | 496 Million | 400 Million |
Other Investing Activities | -199 Million | -15 Million | -268 Million | 172 Million | 362 Million | 318 Million |
Financing Cash Flow | -2.96 Billion | -2.92 Billion | -2.36 Billion | -2.2 Billion | -1.93 Billion | -3.55 Billion |
Debt repayment | - | - | - | - | - | -1.5 Billion |
Dividends payments | -2.3 Billion | -2.43 Billion | -1.89 Billion | -1.75 Billion | -1.89 Billion | -1.75 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -668 Million | -490 Million | -472 Million | -448 Million | -40 Million | -301 Million |
Accounts receivables | 205 Million | -192 Million | -1.02 Billion | 56 Million | 1.35 Billion | -1.24 Billion |
Accounts payables | -2.98 Billion | 682 Million | -1.38 Billion | 1.58 Billion | -491 Million | -332 Million |
Inventory | 936 Million | -6.93 Billion | 171 Million | -995 Million | -322 Million | 463 Million |
Other working capital | -390 Million | -597 Million | 305 Million | 92 Million | -1.3 Billion | -1.64 Billion |
Cash at beginning of period | 31.07 Billion | 35.2 Billion | 32.58 Billion | 29 Billion | 25.89 Billion | 27.29 Billion |
Cash at end of period | 31.21 Billion | 31.07 Billion | 35.2 Billion | 32.58 Billion | 29 Billion | 25.89 Billion |
Capital Expenditure | -1.97 Billion | -1.71 Billion | -1.08 Billion | -1.25 Billion | -1.4 Billion | -1.9 Billion |
Effect of forex changes on cash | 241 Million | 1.65 Billion | 642 Million | 25 Million | -426 Million | -24 Million |
Net cash flow / Change in cash | 135 Million | -4.13 Billion | 2.62 Billion | 3.57 Billion | 3.11 Billion | -1.4 Billion |
Free Cash Flow | 2.96 Billion | -1.99 Billion | 4.06 Billion | 6.11 Billion | 5.33 Billion | 2.78 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.13 Billion | 2.69 Billion | 730 Million | 4.44 Billion | -21 Million | 880 Million |
Depreciation & Amortization | - | - | 642 Million | 2.25 Billion | 578 Million | 533 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -2.23 Billion | - | - |
Other non-cash items | -2.13 Billion | -2.69 Billion | -730 Million | 470 Million | 21 Million | -880 Million |
Investing Cash Flow | - | - | - | -2.07 Billion | - | - |
Investments in PPE | - | - | - | -1.97 Billion | - | - |
Acquisitions | - | - | - | -3 Million | - | - |
Investment purchases | - | - | - | -4.09 Billion | - | - |
Sales/Maturities of investments | - | - | - | 4.19 Billion | - | - |
Other Investing Activities | - | - | - | -199 Million | - | - |
Financing Cash Flow | - | - | - | -2.96 Billion | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | -2.3 Billion | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | -668 Million | - | - |
Accounts receivables | - | - | - | 205 Million | - | - |
Accounts payables | - | - | - | -2.98 Billion | - | - |
Inventory | - | - | - | 936 Million | - | - |
Other working capital | - | - | - | -390 Million | - | - |
Cash at beginning of period | - | - | 35.53 Billion | 31.07 Billion | 34.6 Billion | 33.74 Billion |
Cash at end of period | - | - | 31.21 Billion | 31.21 Billion | 35.53 Billion | 34.6 Billion |
Capital Expenditure | - | - | - | -1.97 Billion | - | - |
Effect of forex changes on cash | - | - | - | 241 Million | - | - |
Net cash flow / Change in cash | - | - | -4.31 Billion | 135 Million | 921 Million | 868 Million |
Free Cash Flow | - | - | 1.28 Billion | 2.96 Billion | 1.15 Billion | 1.06 Billion |
0HOH
BIOEX
GXI
050890
5821
GEN